Why the study?
Does adult height predict incident ASCVD and AFib in a multiethnic cohort?
Cohort (n=6,814)
Does adult height predict incident ASCVD and AFib in a multiethnic cohort?
Tall stature is associated with a reduced risk of incident ASCVD but an increased risk of incident atrial fibrillation, independent of traditional risk factors and CAC score.
Should not yet inform clinical risk assessment by height; leaves open causal links to ASCVD and AF.
We assessed the relationships among adult height, coronary artery calcium (CAC) score, incident atherosclerotic cardiovascular disease (ASCVD) events, and atrial fibrillation (AFib) in a multiethnic cohort. We used race/ethnicity-specific height (dichotomized by median value and in quartiles) as the predictor variable within the 4 racial/ethnic groups in the Multi-Ethnic Study of Atherosclerosis (n = 6,814). After a mean of 10.2 years of follow-up (2000-2012), 556 ASCVD events (8.2%) and 539 AFib events (7.9%) occurred. Adult height was not associated with prevalent CAC score (ln(CAC + 1) or categories). Tall stature (i.e., race/ethnicity-specific height ≥median) had a significant but opposite association with future ASCVD and AFib (hazard ratios were 0.72 (95% confidence interval: 0.56, 0.92) and 1.38 (95% confidence interval: 1.07, 1.79), respectively). We observed a gradient-response but opposite association between quartiles of race/ethnicity-specific height and ASCVD/AFib events in our multivariable models. A formal test of interaction between race/ethnicity-specific height and sex was not significant in the ASCVD model (P = 0.78) but was significant in the AFib model (P = 0.03). Tall stature was associated (in a gradient-response fashion) with reduced risk of ASCVD events and increased risk of AFib. Adult height may signal interactions between genetic and environmental factors and may provide risk information independent of current traditional risk factors and CAC score.
No takes yet. Share an insight, caveat, or question.
Yeboah et al. (2017) conducted a cohort in Atherosclerotic cardiovascular disease and atrial fibrillation (n=6,814). Tall stature (race/ethnicity-specific height ≥median) vs. Shorter stature (<median) was evaluated on Incident atherosclerotic cardiovascular disease (ASCVD) events (HR 0.72, 95% CI 0.56-0.92).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: